Abstract

Nuclear factor erythroid 2–related factor 2 (Nrf2) is a master transcriptional regulator that plays a central role in 
cellular defense mechanisms, particularly in combating oxidative stress. It exerts its effects by orchestrating the 
expression of a wide array of antioxidant, detoxifying, and cytoprotective genes, thereby maintaining redox 
homeostasis and protecting cells from oxidative damage. Beyond this classical role, growing evidence highlights the 
broader involvement of Nrf2 in regulating immune function and inflammatory responses. Through cross-talk with 
signaling pathways such as NF-κB and MAPKs, Nrf2 modulates the expression of cytokines, chemokines, and other 
inflammatory mediators, thereby influencing both innate and adaptive immunity. Dysregulation or impaired 
activation of Nrf2 has been implicated in the pathogenesis of several inflammatory and autoimmune disorders, 
including rheumatoid arthritis, multiple sclerosis, asthma, and chronic obstructive pulmonary disease. These 
findings underscore its relevance not only in oxidative stress responses but also in disease progression and immune 
regulation. Recent advances in pharmacology and nutraceutical research have identified small-molecule activators 
and natural compounds, such as polyphenols and isothiocyanates, that can enhance Nrf2 signaling. Harnessing these 
therapeutic strategies offers promising opportunities for controlling excessive inflammation and oxidative injury. 
Understanding the multifaceted roles of Nrf2 provides a foundation for novel interventions in chronic inflammatory 
diseases.